INS and type 2 diabetes mellitus: Srinivasan et al. [119] reported that tigerinin-1R (RVCSAIPLPICH) enhances insulin release and improves glucose tolerance, suggesting that tigerinin-1R shows potential for development into novel therapeutic agents for treatment of type 2 diabetes mellitus.